{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:49:11Z","timestamp":1777441751755,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T00:00:00Z","timestamp":1384732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2172-14-51","type":"journal-article","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T17:15:45Z","timestamp":1384794945000},"source":"Crossref","is-referenced-by-count":5,"title":["Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse models"],"prefix":"10.1186","volume":"14","author":[{"given":"Martin","family":"Tolstrup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Toft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn S","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Funding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shervin","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mogens","family":"Duch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,18]]},"reference":[{"key":"554_CR1","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","volume":"371","author":"CL Leonardi","year":"2008","unstructured":"Leonardi CL, Kimball AB: Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet. 2008, 371: 1665-1674. 10.1016\/S0140-6736(08)60725-4.","journal-title":"Lancet"},{"key":"554_CR2","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","volume":"366","author":"C Leonardi","year":"2012","unstructured":"Leonardi C, Matheson R: Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med. 2012, 366: 1190-1199. 10.1056\/NEJMoa1109997.","journal-title":"N Engl J Med"},{"key":"554_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.autrev.2007.03.003","volume":"7","author":"G Valesini","year":"2007","unstructured":"Valesini G, Iannuccelli C: Biological and clinical effects of anti-TNFalpha treatment. Autoimmun Rev. 2007, 7: 35-41. 10.1016\/j.autrev.2007.03.003.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"554_CR4","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.4049\/jimmunol.1002300","volume":"185","author":"FL Craciun","year":"2010","unstructured":"Craciun FL, Schuller ER, Remick DG: Early enhanced local neutrophil recruitment in peritonitis-induced sepsis improves bacterial clearance and survival. J Immunol. 2010, 185 (11): 6930-6938. 10.4049\/jimmunol.1002300.","journal-title":"J Immunol"},{"issue":"10","key":"554_CR5","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1097\/01.CCM.0000284511.73556.59","volume":"35","author":"J Villar","year":"2007","unstructured":"Villar J, P\u00e9rez-M\u00e9ndez L: A CXCL2 polymorphism is associated with better outcomes in patients with severe sepsis. Crit Care Med. 2007, 35 (10): 2292-2297. 10.1097\/01.CCM.0000284511.73556.59.","journal-title":"Crit Care Med"},{"issue":"7","key":"554_CR6","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.4049\/jimmunol.1001310","volume":"185","author":"SD Kim","year":"2010","unstructured":"Kim SD, Kim YK: The agonists of formyl peptide receptors prevent development of severe sepsis after microbial infection. J Immunol. 2010, 185 (7): 4302-4310. 10.4049\/jimmunol.1001310.","journal-title":"J Immunol"},{"key":"554_CR7","first-page":"10","volume":"9","author":"A Hillenbrand","year":"2010","unstructured":"Hillenbrand A, Knippschild U: Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients. BMC Surg. 2010, 9: 10-26.","journal-title":"BMC Surg"},{"issue":"3","key":"554_CR8","first-page":"155","volume":"18","author":"H Hamishehkar","year":"2010","unstructured":"Hamishehkar H, Beigmohammadi MT: Identification of enhanced cytokine generation following sepsis. Dream of magic bullet for mortality prediction and therapeutic evaluation. Daru. 2010, 18 (3): 155-162.","journal-title":"Daru"},{"issue":"3","key":"554_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1084\/jem.158.3.885","volume":"18","author":"GJ Cianciolo","year":"1983","unstructured":"Cianciolo GJ, Lostrom ME: Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E. J Exp Med. 1983, 18 (3): 885-900.","journal-title":"J Exp Med"},{"key":"554_CR10","first-page":"443","volume":"39","author":"LC Hebebrand","year":"1979","unstructured":"Hebebrand LC, Olsen RG: Inhibition of human lymphocyte mitogen and antigen response by a 1,000-dalton protein from feline leukemia virus. Cancer Res. 1979, 39: 443-447.","journal-title":"Cancer Res"},{"issue":"6","key":"554_CR11","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.4049\/jimmunol.124.6.2900","volume":"124","author":"GJ Cianciolo","year":"1980","unstructured":"Cianciolo GJ, Matthews TJ: Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses. J Immunol. 1980, 124 (6): 2900-2905.","journal-title":"J Immunol"},{"issue":"25","key":"554_CR12","doi-asserted-by":"publisher","first-page":"14920","DOI":"10.1073\/pnas.95.25.14920","volume":"95","author":"M Mangeney","year":"1998","unstructured":"Mangeney M, Heidmann T: Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc Natl Acad Sci USA. 1998, 95 (25): 14920-14925. 10.1073\/pnas.95.25.14920.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"51","key":"554_CR13","doi-asserted-by":"publisher","first-page":"20534","DOI":"10.1073\/pnas.0707873105","volume":"104","author":"M Mangeney","year":"2007","unstructured":"Mangeney M, Renard M: Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci USA. 2007, 104 (51): 20534-20539. 10.1073\/pnas.0707873105.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4724","key":"554_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.2996136","volume":"230","author":"GJ Cianciolo","year":"1985","unstructured":"Cianciolo GJ, Copeland TD: Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science. 1985, 230 (4724): 453-455. 10.1126\/science.2996136.","journal-title":"Science"},{"issue":"1","key":"554_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0165-2478(88)90112-5","volume":"19","author":"GJ Cianciolo","year":"1988","unstructured":"Cianciolo GJ, Bogerd H, Snyderman R: Human retrovirus-related synthetic peptides inhibit T lymphocyte proliferation. Immunol Lett. 1988, 19 (1): 7-13. 10.1016\/0165-2478(88)90112-5.","journal-title":"Immunol Lett"},{"issue":"14","key":"554_CR16","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1096\/fj.06-6151com","volume":"20","author":"K Yaddanapudi","year":"2006","unstructured":"Yaddanapudi K, Palacios G: Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 2006, 20 (14): 2519-2530. 10.1096\/fj.06-6151com.","journal-title":"FASEB J"},{"issue":"2","key":"554_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1096\/fj.06-7061com","volume":"21","author":"I Bloch","year":"2007","unstructured":"Bloch I, Quintana FJ: T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif. FASEB J. 2007, 21 (2): 393-401. 10.1096\/fj.06-7061com.","journal-title":"FASEB J"},{"key":"554_CR18","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1073\/pnas.92.8.3611","volume":"92","author":"S Haraguchi","year":"1995","unstructured":"Haraguchi S, Good RA: Differential modulation of Th1 and Th2 related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc Natl Acad Sci USA. 1995, 92: 3611-3615. 10.1073\/pnas.92.8.3611.","journal-title":"Proc Natl Acad Sci USA"},{"key":"554_CR19","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.4049\/jimmunol.136.10.3517","volume":"136","author":"RA Harrell","year":"1986","unstructured":"Harrell RA, Cianciolo GJ: Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal retroviruses. J Immunol. 1986, 136: 3517-3520.","journal-title":"J Immunol"},{"key":"554_CR20","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.4049\/jimmunol.139.7.2329","volume":"139","author":"ES Kleinerman","year":"1987","unstructured":"Kleinerman ES, Lachman LB: A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte mediated killing by inactivating interleukin 1. J Immunol. 1987, 139: 2329-2337.","journal-title":"J Immunol"},{"issue":"4","key":"554_CR21","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.4049\/jimmunol.0902185","volume":"184","author":"FD Finkelman","year":"2010","unstructured":"Finkelman FD, Hogan SP: Importance of cytokines in murine allergic airway disease and human asthma. J Immunol. 2010, 184 (4): 1663-1674. 10.4049\/jimmunol.0902185.","journal-title":"J Immunol"},{"issue":"1","key":"554_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/MCP.0b013e3283413105","volume":"17","author":"J Corren","year":"2011","unstructured":"Corren J: Cytokine inhibition in severe asthma: current knowledge and future directions. Curr Opin Pulm Med. 2011, 17 (1): 29-33. 10.1097\/MCP.0b013e3283413105.","journal-title":"Curr Opin Pulm Med"},{"key":"554_CR23","first-page":"w13108","volume":"140","author":"L Delavall\u00e9e","year":"2010","unstructured":"Delavall\u00e9e L, Duvallet E: Anti-cytokine vaccination in autoimmune diseases. Swiss Med Wkly. 2010, 140: w13108-","journal-title":"Swiss Med Wkly"},{"key":"554_CR24","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/jid.2008.322","volume":"129","author":"AT Funding","year":"2009","unstructured":"Funding AT, Johansen C: Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice. J Invest Dermatol. 2009, 129: 891-898. 10.1038\/jid.2008.322.","journal-title":"J Invest Dermatol"},{"key":"554_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2340\/00015555-1046","volume":"91","author":"LL Lilleholt","year":"2011","unstructured":"Lilleholt LL, Johansen C: Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-O-tetradecanoylphorbol 13-acetate. Acta Derm Venereol. 2011, 91: 271-278. 10.2340\/00015555-1046.","journal-title":"Acta Derm Venereol"},{"key":"554_CR26","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.4049\/jimmunol.166.11.6771","volume":"166","author":"A Takahashi","year":"2001","unstructured":"Takahashi A, Day NK: A retroviral-derived immunosuppressive peptide activates mitogen-activated protein kinases. J Immunol. 2001, 166: 6771-6775.","journal-title":"J Immunol"},{"issue":"12","key":"554_CR27","doi-asserted-by":"publisher","first-page":"e52693","DOI":"10.1371\/journal.pone.0052693","volume":"7","author":"GJ Cianciolo","year":"2012","unstructured":"Cianciolo GJ, Pizzo SV: Anti-inflammatory and vasoprotective activity of a retroviral-derived peptide, homologous to human endogenous retroviruses: endothelial cell effects. PLoS One. 2012, 7 (12): e52693-10.1371\/journal.pone.0052693.","journal-title":"PLoS One"},{"issue":"7","key":"554_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.tibs.2013.04.003","volume":"38","author":"A Ashkenazi","year":"2013","unstructured":"Ashkenazi A, Faingold O: HIV-1 fusion protein exerts complex immunosuppressive effects. Trends Biochem Sci. 2013, 38 (7): 345-349. 10.1016\/j.tibs.2013.04.003.","journal-title":"Trends Biochem Sci"},{"key":"554_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1742-4690-9-67","volume":"9","author":"VA Morozov","year":"2012","unstructured":"Morozov VA, Morozov AV: Single mutations in the transmembrane envelope protein abrogate the immunosuppressive properties of HIV-1. Retrovirology. 2012, 9: 67-10.1186\/1742-4690-9-67.","journal-title":"Retrovirology"},{"key":"554_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejphar.2011.04.037","volume":"662","author":"G Kalyan Kumar","year":"2011","unstructured":"Kalyan Kumar G, Dhamotharan R: Embelin reduces cutaneous TNF-\u03b1 level and ameliorates skin edema in acute and chronic model of skin inflammation in mice. Eur J Pharmacol. 2011, 662: 63-69. 10.1016\/j.ejphar.2011.04.037.","journal-title":"Eur J Pharmacol"},{"key":"554_CR31","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/jid.2012.163","volume":"132","author":"KA Papp","year":"2012","unstructured":"Papp KA, Reid C: Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial. J Invest Dermatol. 2012, 132: 2466-2469. 10.1038\/jid.2012.163.","journal-title":"J Invest Dermatol"},{"key":"554_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","volume":"50","author":"JB Galloway","year":"2011","unstructured":"Galloway JB, Hyrich KL: Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6\u00a0months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology. 2011, 50: 124-131. 10.1093\/rheumatology\/keq242.","journal-title":"Rheumatology"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2172-14-51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2172-14-51\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2172-14-51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T19:52:59Z","timestamp":1688673179000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/1471-2172-14-51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,18]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1186\/1471-2172-14-51","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,18]]},"article-number":"51"}}